- Home
- PCVX vs WNS Comparison
PCVX vs WNS Comparison
Compare PCVX & WNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- WNS
- Stock Information
- Founded
- PCVX 2013
- WNS 1996
- Country
- PCVX United States
- WNS India
- Employees
- PCVX N/A
- WNS N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- WNS Business Services
- Sector
- PCVX Health Care
- WNS Consumer Discretionary
- Exchange
- PCVX Nasdaq
- WNS Nasdaq
- Market Cap
- PCVX 4.0B
- WNS 3.2B
- IPO Year
- PCVX 2020
- WNS N/A
- Fundamental
- Price
- PCVX $43.49
- WNS $76.47
- Analyst Decision
- PCVX Strong Buy
- WNS Hold
- Analyst Count
- PCVX 8
- WNS 7
- Target Price
- PCVX $114.17
- WNS $68.00
- AVG Volume (30 Days)
- PCVX 2.2M
- WNS 1.4M
- Earning Date
- PCVX 11-04-2025
- WNS 10-16-2025
- Dividend Yield
- PCVX N/A
- WNS N/A
- EPS Growth
- PCVX N/A
- WNS 21.19
- EPS
- PCVX N/A
- WNS 3.60
- Revenue
- PCVX N/A
- WNS $1,345,621,000.00
- Revenue This Year
- PCVX N/A
- WNS $7.23
- Revenue Next Year
- PCVX N/A
- WNS $9.29
- P/E Ratio
- PCVX N/A
- WNS $21.25
- Revenue Growth
- PCVX N/A
- WNS 1.94
- 52 Week Low
- PCVX $27.66
- WNS $42.62
- 52 Week High
- PCVX $118.62
- WNS $76.48
- Technical
- Relative Strength Index (RSI)
- PCVX 68.94
- WNS 77.64
- Support Level
- PCVX $42.75
- WNS $76.28
- Resistance Level
- PCVX $45.12
- WNS $76.39
- Average True Range (ATR)
- PCVX 2.10
- WNS 0.08
- MACD
- PCVX 0.41
- WNS -0.07
- Stochastic Oscillator
- PCVX 84.68
- WNS 95.45
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About WNS WNS (Holdings) Limited Sponsored ADR (Jersey)
WNS (Holdings) Ltd is a provider of business process management (BPM) services, offering comprehensive data, voice, analytical, and business transformation services with a blended onshore, nearshore and offshore delivery model. The company's segment includes Banking/Financial Services, and Insurance; Travel, Shipping/Logistics, and Utilities; Manufacturing/Retail/Consumer, Hi-tech/Professional Services, and Procurement; Healthcare/Life Sciences. Geographically, the company generates the majority of its revenue from North America (primarily the US), followed by the UK. The company also has a presence in Australia, Europe (excluding the UK), South Africa, and other countries.